FFCP PHASE2:Hg19::chr3:63953435..63953499,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p1@ATXN7 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_ATXN7_5end |
Coexpression cluster: | C18_CD4_CD8_thymus_Whole_Peripheral_Natural_blood |
Association with transcript: | 0bp_to_ENST00000475897, uc010hnw.2, uc011bfn.1_5end |
EntrezGene: | ATXN7 |
HGNC: | 10560 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@ATXN7 |
---|
0
50
100
150
200
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
hematopoietic stem cell | 7.93e-28 | 168 |
hematopoietic cell | 5.54e-25 | 177 |
hematopoietic oligopotent progenitor cell | 6.69e-23 | 161 |
hematopoietic multipotent progenitor cell | 6.69e-23 | 161 |
mature alpha-beta T cell | 3.84e-22 | 18 |
alpha-beta T cell | 3.84e-22 | 18 |
immature T cell | 3.84e-22 | 18 |
mature T cell | 3.84e-22 | 18 |
immature alpha-beta T cell | 3.84e-22 | 18 |
T cell | 6.93e-21 | 25 |
Showing 1 to 10 of 21 entries
Ontology term | p-value | n |
---|---|---|
adult organism | 6.66e-13 | 114 |
blood | 1.86e-10 | 15 |
haemolymphatic fluid | 1.86e-10 | 15 |
organism substance | 1.86e-10 | 15 |
hematopoietic system | 1.84e-08 | 98 |
blood island | 1.84e-08 | 98 |
hemolymphoid system | 6.79e-08 | 108 |
Showing 1 to 7 of 7 entries
Ontology term | p-value | n |
---|---|---|
leukemia | 8.29e-13 | 39 |
myeloid leukemia | 3.27e-11 | 31 |
hematologic cancer | 1.29e-09 | 51 |
immune system cancer | 1.29e-09 | 51 |
Showing 1 to 4 of 4 entries